Genome-wide expression studies in autism spectrum disorder, Rett syndrome, and Down syndrome.
Though different in their aetiology, autism spectrum disorder (ASD), Rett syndrome (RTT) and Down syndrome (DS) are three neurodevelopmental disorders sharing significant clinical and neuropathological overlaps. Genome-wide expression studies are reviewed and available datasets from post-mortem brains reanalyzed to identify genes and gene pathways dysregulated in all three disorders. Our results surprisingly converge upon immune, and not neurodevelopmental genes, as the most consistently shared abnormality in genome-wide expression patterns. A dysregulated immune response, accompanied by enhanced oxidative stress and abnormal mitochondrial metabolism seemingly represents the common molecular underpinning of these neurodevelopmental disorders. This conclusion may be important for the definition of pharmacological therapies able to ameliorate clinical symptoms across these disorders.
Laboratory of Molecular Psychiatry and Neurogenetics, University Campus Bio-Medico, Rome, Italy.
Carla
C
Lintas
Roberto
R
Sacco
Antonio M
AM
Persico
D001921:Brain / Q000378:metabolism*; D002648:Child; D002659:Child Development Disorders, Pervasive / Q000235:genetics* / Q000378:metabolism; D004314:Down Syndrome / Q000235:genetics* / Q000378:metabolism; D015870:Gene Expression; D055106:Genome-Wide Association Study; D006801:Humans; D015518:Rett Syndrome / Q000235:genetics* / Q000378:metabolism